Pocket Naloxone Corp
Quick facts
Phase 3 pipeline
- Naloxone Nasal Spray · Emergency Medicine / Toxicology
Naloxone is a competitive opioid receptor antagonist that rapidly blocks opioid effects and reverses opioid overdose.
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: